Wnt signaling in remyelination in multiple sclerosis: Friend or foe?

Molecular Neurobiology

Volumn 49, Issue 3, 2014, Pages 1117-1125

  Xie, Chong ^a   Li, Zezhi ^a   Zhang, Guang Xian ^a   Guan, Yangtai ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Multiple sclerosis; Oligodendrocytes; Remyelination; Wnt signaling

Indexed keywords

WNT PROTEIN;

ARTICLE; DEMYELINATING DISEASE; FUNCTIONAL DISEASE; HUMAN; MULTIPLE SCLEROSIS; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PROTEIN ANALYSIS; PROTEIN FUNCTION; REMYELINIZATION; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; MYELIN SHEATH; MYELINATED NERVE; PATHOLOGY; PHYSIOLOGY; WNT SIGNALING PATHWAY;

ANIMALS; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE FIBERS, MYELINATED; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84902536589     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8584-6     Document Type: Article

References (75)

1. Goldschmidt T, Antel J, Konig FB, Bruck W, Kuhlmann T (2009) Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72(22):1914 - 1921. doi:10.1212/WNL.0b013e3181a8260a
2. Stadelmann C, Bruck W (2008) Interplay between mechanisms of damage and repair in multiple sclerosis. J Neurol 255(Suppl 1):12-18. doi:10.1007/s00415- 008-1003-7 (Pubitemid 351341868)
3. Maurer M, Dachsel R, Domke S, Ries S, Reifschneider G, Friedrich A, Knorn P, Landefeld H, Niemczyk G, Schicklmaier P, Wernsdorfer C, Windhagen S, Albrecht H, Schwab S (2011) Health care situation of patients with relapsing-remitting multiple sclerosis receiving immunomodulatory therapy: a retrospective survey of more than 9000 German patients with MS. Eur J Neurol 18(8):1036-1045. doi:10.1111/j.1468-1331.2010.03313.x
4. Remington GM, Treadaway K, Frohman T, Salter A, Stuve O, Racke MK, Hawker K, Agosta F, Sormani MP, Filippi M, Frohman EM (2010) A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolatemofetil in early relapsing-remitting multiple sclerosis (TIME MS). Ther Adv Neurol Disord 3(1):3-13. doi:10.1177/1756285609355851
5. Fazekas F, Strasser-Fuchs S, Hommes OR (2007) Intravenous immunoglobulin in MS: promise or failure? J Neurol Sci 259(1-2):61-66. doi:10.1016/j.jns.2006. 12.018 (Pubitemid 47031204)
6. Hoffmann V, Kuhn W, Schimrigk S, Islamova S, Hellwig K, Lukas C, Brune N, Pohlau D, Przuntek H, Muller T (2006) Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients. Eur J Neurol 13(1):72-76. doi:10.1111/j.1468-1331.2006.01145.x
7. Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T (2005) Treatment with laquinimod reduces development of active MRI lesions in relapsing MS. Neurology 64(6):987-991. doi:10.1212/01.WNL.0000154520.48391.69 (Pubitemid 40388448)
8. Fancy SP, Zhao C, Franklin RJ (2004) Increased expression of Nkx2.2 andOlig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27(3):247-254. doi:10.1016/j.mcn.2004.06.015 (Pubitemid 39433839)
9. Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, Rowitch DH, Kessaris N, Suter U, Richardson WD, Franklin RJ (2010) CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6(6):578-590. doi:10.1016/j.stem.2010.04.002
10. van Amerongen R, Nusse R (2009) Towards an integrated view of Wnt signaling in development. Development 136(19):3205-3214. doi:10.1242/dev.033910
11. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR 3rd, Nusse R (2003)Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423(6938):448-452. doi:10.1038/nature01611 (Pubitemid 36626997)
12. Bejsovec A (2005) Wnt pathway activation: new relations and locations. Cell 120(1):11-14. doi:10.1016/j.cell.2004.12.021
13. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease.AnnuRev CellDev Biol 20:781-810. doi:10.1146/annurev.cellbio.20.010403. 113126 (Pubitemid 39488658)
14. Fiedler M, Mendoza-Topaz C, Rutherford TJ, Mieszczanek J, Bienz M (2011) Dishevelled interacts with the DIX domain polymerization interface of Axin to interfere with its function in down-regulating beta-catenin. Proc Natl Acad Sci U S A 108(5):1937-1942. doi:10.1073/pnas.1017063108
15. Hutchins BI, Li L, Kalil K (2012) Wnt-induced calcium signaling mediates axon growth and guidance in the developing corpus callosum. Sci Signal 5(206):pt1. doi:10.1126/scisignal.2002523
16. Ciani L, Boyle KA, Dickins E, Sahores M, Anane D, Lopes DM, Gibb AJ, Salinas PC (2011) Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca(2)(+)/Calmodulin-dependent protein kinase II. Proc Natl Acad Sci U S A 108(26):10732-10737. doi:10.1073/pnas.1018132108
17. Lee MA, Park HJ, Chung HJ, Kim WK, Lee SK (2013) Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of beta-catenin signaling. J Nat Prod. doi:10.1021/np400216m
18. Avasarala S, Van Scoyk M, Wang J, Sechler M, Vandervest K, Brzezinski C, Weekes C, Edwards MG, Arcaroli J, Davis RE, Bikkavilli RK, Winn RA (2013) hsa-miR29b, a critical downstream target of non-canonicalWnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression. Biol Open 2(7):675-685. doi:10.1242/bio.20134507
19. Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F, Lin J (2013) miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. The FEBS journal. doi:10.1111/febs.12417
20. Julio MK, Shibata M, Desai N, Reynon M, Halili MV, Hu YP, Price SM, Abate-Shen C, Shen MM (2013) Canonical Wnt signaling regulates Nkx3.1 expression and luminal epithelial differentiation during prostate organogenesis. Dev Dynam. doi:10.1002/dvdy.24008
21. Tuller T, Atar S, Ruppin E, GurevichM, Achiron A (2013) Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases. Genes Immun 14(2):67-82. doi:10.1038/gene.2012.55
22. Lie DC, Colamarino SA, Song HJ, Desire L, Mira H, Consiglio A, Lein ES, Jessberger S, Lansford H, Dearie AR, Gage FH (2005) Wnt signalling regulates adult hippocampal neurogenesis. Nature 437(7063):1370-1375. doi:10.1038/ nature04108 (Pubitemid 41568684)
23. Azim K, Butt AM (2011) GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 59(4):540-553. doi:10.1002/glia.21122
24. Feigenson K, Reid M, See J, Crenshaw IE, Grinspan JB (2011) Canonical Wnt signalling requires the BMP pathway to inhibit oligodendrocyte maturation. ASN Neuro 3(3):e00061. doi:10.1042/AN20110004
25. Memezawa A, Takada I, Takeyama K, Igarashi M, Ito S, Aiba S, Kato S, Kouzmenko AP (2007) Id2 gene-targeted crosstalk between Wnt and retinoid signaling regulates proliferation in human keratinocytes. Oncogene 26(35):5038 - 5045. doi:10.1038/sj.onc.1210320
26. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303(5663):1483 -1487. doi:10.1126/science.1094291
27. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23(13):1571-1585. doi:10.1101/gad.1806309
28. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H, Hsieh J, Bassel-Duby R, Olson EN, Lu QR (2009) HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 12(7):829-838. doi:10.1038/nn.2333
29. Lang J, Maeda Y, Bannerman P, Xu J, Horiuchi M, Pleasure D, Guo F (2013) Adenomatous polyposis coli regulates oligodendroglial development. J Neurosci 33(7):3113-3130. doi:10.1523/JNEUROSCI. 3467-12.2013
30. Chew LJ, Shen W, Ming X, Senatorov VV Jr, Chen HL, Cheng Y, Hong E, Knoblach S, Gallo V (2011) SRY-box containing gene 17 regulates theWnt/beta-catenin signaling pathway in oligodendrocyte progenitor cells. J Neurosci 31(39):13921 - 13935. doi:10.1523/JNEUROSCI.3343-11.2011
31. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, Lytle J, Nait-Oumesmar B, Kerninon C, Kanai-Azuma M, Kanai Y, Gallo V (2006) Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci 26(38):9722-9735. doi:10.1523/JNEUROSCI.1716-06.2006 (Pubitemid 44427711)
32. Chen HL, Chew LJ, Packer RJ, Gallo V (2013) Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation. Cancer Lett 335(2):361-371. doi:10.1016/j.canlet.2013.02.058
33. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, BirchmeierW, Behrens J (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22(4):1184-1193 (Pubitemid 34094854)
34. Zeng YA, Nusse R (2010) Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 6(6):568-577. doi:10.1016/j.stem.2010.03.020
35. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22(4):1172-1183 (Pubitemid 34094853)
36. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280(5363):596-599
37. Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ, Huang EJ, Nusse R, Franklin RJ, Rowitch DH (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14(8):1009-1016. doi:10.1038/nn.2855
38. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, Hild M, Shi X, Wilson CJ, Mickanin C, Myer V, Fazal A, Tomlinson R, Serluca F, ShaoW, Cheng H, ShultzM, Rau C, SchirleM, Schlegl J, Ghidelli S, Fawell S, Lu C, Curtis D, Kirschner MW, Lengauer C, Finan PM, Tallarico JA, Bouwmeester T, Porter JA, Bauer A, Cong F (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461(7264):614-620. doi:10.1038/nature08356
39. Willert K, Nusse R (1998) Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8(1):95-102 (Pubitemid 28122147)
40. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127(3):469-480. doi:10.1016/j.cell.2006.10.018
41. He Y, Dupree J, Wang J, Sandoval J, Li J, Liu H, Shi Y, Nave KA, Casaccia-Bonnefil P (2007) The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55(2):217-230. doi:10.1016/j.neuron.2007.06.029 (Pubitemid 47048909)
42. Kawasoe T, Furukawa Y, Daigo Y, Nishiwaki T, Ishiguro H, Fujita M, Satoh S, Miwa N, Nagasawa Y, Miyoshi Y, Ogawa M, Nakamura Y (2000) Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by betacatenin. Cancer Res 60(13):3354-3358 (Pubitemid 30482145)
43. Zara F, Biancheri R, Bruno C, Bordo L, Assereto S, Gazzerro E, Sotgia F, Wang XB, Gianotti S, Stringara S, Pedemonte M, Uziel G, Rossi A, Schenone A, Tortori-Donati P, van der Knaap MS, Lisanti MP, Minetti C (2006) Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract. Nat Genet 38(10):1111-1113. doi:10.1038/ng1870 (Pubitemid 44470355)
44. Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, Casaccia-Bonnefil P (2008) Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 11(9):1024-1034. doi:10.1038/nn.2172
45. Jacob C, Lebrun-Julien F, Suter U (2011) How histone deacetylases control myelination. Mol Neurobiol 44(3):303-312. doi:10.1007/s12035-011-8198-9
46. Liu A, Niswander LA (2005) Bone morphogenetic protein signalling and vertebrate nervous system development. Nat Rev Neurosci 6(12):945-954. doi:10.1038/nrn1805 (Pubitemid 41753088)
47. Liem KF Jr, Tremml G, Roelink H, Jessell TM (1995) Dorsal differentiation of neural plate cells induced byBMP-mediated signals from epidermal ectoderm. Cell 82(6):969-979
48. See JM, Grinspan JB (2009) Sending mixed signals: bone morphogenetic protein in myelination and demyelination. J Neuropathol Exp Neurol 68(6):595-604. doi:10.1097/NEN.0b013e3181a66ad9
49. Samanta J, Kessler JA (2004) Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131(17):4131- 4142. doi:10.1242/dev.01273
50. Cheng X, Wang Y, He Q, Qiu M, Whittemore SR, Cao Q (2007) Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells 25(12):3204-3214. doi:10.1634/stemcells.2007-0284 (Pubitemid 350294446)
51. HamptonDW, Asher RA, Kondo T, Steeves JD, RamerMS, Fawcett JW (2007) A potential role for bonemorphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo. Eur J Neurosci 26(11):3024-3035. doi:10.1111/j.1460-9568.2007.05940.x (Pubitemid 350135185)
52. Kim NC, Marques G (2010) Identification of downstream targets of the bone morphogenetic protein pathway in the Drosophila nervous system. Dev Dynam 239(9):2413-2425. doi:10.1002/dvdy.22368
53. WuM, HernandezM, Shen S, Sabo JK, Kelkar D, Wang J, O'Leary R, Phillips GR, Cate HS, Casaccia P (2012) Differentialmodulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation. J Neurosci 32(19):6651-6664. doi:10.1523/JNEUROSCI.4876-11.2012
54. Weng Q, Chen Y, Wang H, Xu X, Yang B, He Q, Shou W, Chen Y, Higashi Y, van den Berghe V, Seuntjens E, Kernie SG, Bukshpun P, Sherr EH, Huylebroeck D, Lu QR (2012) Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system. Neuron 73(4):713-728. doi:10.1016/j.neuron.2011.12.021
55. Ortega F, Gascon S, Masserdotti G, Deshpande A, Simon C, Fischer J, Dimou L, Chichung Lie D, Schroeder T, Berninger B (2013) Oligodendrogliogenic and neurogenic adult subependymal zone neural stem cells constitute distinct lineages and exhibit differential responsiveness to Wnt signalling. Nat Cell Biol 15(6):602-613. doi:10.1038/ncb2736
56. Kalani MY, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, Weissman IL, Palmer TD, Nusse R (2008) Wnt-mediated selfrenewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A 105(44):16970-16975. doi:10.1073/pnas.0808616105
57. Tawk M, Makoukji J, Belle M, Fonte C, Trousson A, Hawkins T, Li H, Ghandour S, Schumacher M, Massaad C (2011) Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis. J Neurosci 31(10):3729-3742. doi:10.1523/JNEUROSCI.4270-10.2011
58. Fu H, Cai J, CleversH, Fast E, Gray S, Greenberg R, Jain MK, Ma Q, Qiu M, Rowitch DH, Taylor CM, Stiles CD (2009) A genome-wide screen for spatially restricted expression patterns identifies transcription factors that regulate glial development. J Neurosci 29(36):11399-11408. doi:10.1523/JNEUROSCI.0160-09. 2009
59. Fu H, Kesari S, Cai J (2012) Tcf7l2 is tightly controlled during myelin formation. Cell Mol Neurobiol 32(3):345-352. doi:10.1007/s10571-011-9778-y
60. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8(5):500-508. doi:10.1038/nm0502-500 (Pubitemid 34546753)
61. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald GH, Gerlitz B, Robinson WH, Baranzini SE, Grinnell BW, Raine CS, Sobel RA, Han DK, Steinman L (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451(7182):1076-1081. doi:10.1038/nature06559 (Pubitemid 351317445)
62. Nickles D, Chen HP, Li MM, Khankhanian P, Madireddy L, Caillier SJ, Santaniello A, Cree BA, Pelletier D, Hauser SL, Oksenberg JR, Baranzini SE (2013) Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. Hum Mol Genet. doi:10.1093/hmg/ddt267
63. Galimberti D, Macmurray J, Scalabrini D, Fenoglio C, De Riz M, Comi C, Comings D, Cortini F, Villa C, Serpente M, Cantoni C, Ridolfi E, Fardipoor MH, Leone M, Monaco F, Bresolin N, Scarpini E (2011) GSK3beta genetic variability in patients with multiple sclerosis. Neurosci Lett 497(1):46-48. doi:10.1016/j.neulet.2011.04.024
64. De Sarno P, Axtell RC, Raman C, Roth KA, Alessi DR, Jope RS (2008) Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol 181(1):338-345
65. Yuan S, Shi Y, Tang SJ (2012) Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain. J Neuroimmune Pharmacol 7(4):904-913. doi:10.1007/s11481-012-9370-3
66. Rangachari M, Kuchroo VK (2013) Using EAE to better understand principles of immune function and autoimmune pathology. J Autoimmun. doi:10.1016/j.jaut. 2013.06.008
67. Yu Q, Sharma A, Oh SY, Moon HG, Hossain MZ, Salay TM, Leeds KE, Du H, Wu B, Waterman ML, Zhu Z, Sen JM (2009) Tcell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat Immunol 10(9):992-999. doi:10.1038/ni.1762
68. Oestreich KJ, Huang AC, Weinmann AS (2011) The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J Exp Med 208(5):1001-1013. doi:10.1084/jem.20102144
69. Ma J, Wang R, Fang X, Ding Y, Sun Z (2011) Critical role of TCF-1 in repression of the IL-17 gene. PLoS One 6(9):e24768. doi:10.1371/journal.pone. 0024768
70. Chen H, Hsu L, Shia Y, Lin M, Lin C (2012) The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway. Biochem Pharmacol 84(9):1143-1153
71. Wu Y, Zhang Y, Zhang H, Yang X, Wang Y, Ren F, Liu H, Zhai Y, Jia B, Yu J, Chang Z (2010) p15RS attenuates Wnt/{beta}-catenin signaling by disrupting {beta}-catenin.TCF4 Interaction. J Biol Chem 285(45):34621-34631. doi:10.1074/jbc.M110.148791
72. Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Mindo S (2010) Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis. Cancer Res 70(10):4233-4242. doi:10.1158/0008-5472.CAN-09-3470
73. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131(Pt 7):1749-1758. doi:10.1093/brain/awn096 (Pubitemid 351957453)
74. Chang A, TourtellotteWW, Rudick R, Trapp BD(2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346(3):165-173. doi:10.1056/NEJMoa010994 (Pubitemid 34438882)
75. Wolswijk G (2002) Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125(Pt 2):338-349